title: Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study.
abstract: BACKGROUND
  Cholangiocarcinoma, including intra- and extrahepatic cholangiocarcinoma, is a rare but highly lethal cancer. Despite effort in finding the risk factors of cholangiocarcinoma, the causes of most cholangiocarcinoma remain unknown. This study utilized a population-based case-control design using data from the National Health Insurance Research Database (NHIRD) of Taiwan to assess the medical conditions associated with cholangiocarcinoma.
  
  
  METHODS
  5,157 incident cases of cholangiocarcinoma diagnosed during 2004 to 2008 and 20,628 controls matched to the cases on sex, age, and time of diagnosis (reference date for the controls) were identified from the NHIRD. Medical risk factors were ascertained from the NHIRD for each individual. Conditional logistic regression was performed to evaluate the association between cholangiocarcinoma and each medical risk factor.
  
  
  RESULTS
  The results showed that factors associated with an increased risk of cholangiocarcinoma included cholangitis, cholelithiasis, cholecystitis, cirrhosis of liver, alcoholic liver disease, chronic non-alcoholic liver disease, hepatitis B, hepatitis C, diabetes, chronic pancreatitis, inflammatory bowel disease, and peptic ulcer. In addition, sex and age differences were observed.
  
  
  CONCLUSIONS
  This study confirms the association between cholangiocarcinoma and several less established risk factors, including diabetes, inflammatory bowel disease, hepatitis B, hepatitis C, and peptic ulcer (proxy for the presence of Helicobacter Pylori). Future studies should focus on finding additional environmental and genetic causes of cholangiocarcinoma.
authors.affiliation: National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. jeffreychang@nhri.org.tw
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Chang
authors.forename: Chia-Rung
authors.initials: CR
authors.lastname: Tsai
authors.forename: Li-Tzong
authors.initials: LT
authors.lastname: Chen
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D018281:Cholangiocarcinoma / Q000150:complications / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009928:Organ Specificity; D012307:Risk Factors; D017678:Sex Distribution; D013624:Taiwan / Q000453:epidemiology; D055815:Young Adult
references.citation: Hepatology. 2013 Feb;57(2):648-55
references.pmid: 23055147
references.citation: J Hepatol. 2012 Jul;57(1):69-76
references.pmid: 22420979
references.citation: Differentiation. 2005 Jun;73(5):249-60
references.pmid: 16026547
references.citation: Am J Gastroenterol. 2007 May;102(5):1016-21
references.pmid: 17324130
references.citation: Dig Dis Sci. 1992 May;37(5):764-8
references.pmid: 1563321
references.citation: Hepatology. 2009 Jan;49(1):116-23
references.pmid: 19085911
references.citation: Am J Gastroenterol. 2008 Jul;103(7):1716-20
references.pmid: 18557716
references.citation: J Gastroenterol Hepatol. 2012 Oct;27(10):1561-8
references.pmid: 22694354
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):525-34
references.pmid: 18296645
references.citation: Lancet. 2009 Oct 24;374(9699):1449-61
references.pmid: 19683340
references.citation: Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8
references.pmid: 17689296
references.citation: World J Gastroenterol. 2008 Jan 28;14(4):632-5
references.pmid: 18203300
references.citation: Int J Behav Med. 2008 Jan-Mar;15(1):14-20
references.pmid: 18444016
references.citation: World J Surg. 2003 Nov;27(11):1258-70
references.pmid: 14534824
references.citation: Wien Med Wochenschr. 2006 Oct;156(19-20):527-33
references.pmid: 17103289
references.citation: Ann Surg Oncol. 2011 May;18(5):1258-66
references.pmid: 21207172
references.citation: Dig Liver Dis. 2010 Apr;42(4):253-60
references.pmid: 20097142
references.citation: Eur J Cancer. 2010 Apr;46(6):1056-61
references.pmid: 20202823
references.citation: World J Gastroenterol. 2008 Jan 21;14(3):331-7
references.pmid: 18200656
references.citation: Int J Cancer. 2007 Feb 1;120(3):638-41
references.pmid: 17109384
references.citation: Gastroenterology. 2005 Mar;128(3):620-6
references.pmid: 15765398
references.citation: Br J Cancer. 2008 Sep 2;99(5):811-5
references.pmid: 18728671
references.citation: J Viral Hepat. 2010 Oct;17(10):742-8
references.pmid: 20002305
references.citation: Cancer Causes Control. 2001 Dec;12(10):959-64
references.pmid: 11808716
references.citation: World J Gastroenterol. 2011 Jan 14;17(2):249-53
references.pmid: 21246000
references.citation: Br J Cancer. 2009 Jun 2;100(11):1765-70
references.pmid: 19436294
references.citation: Int J Epidemiol. 1996 Oct;25(5):933-40
references.pmid: 8921477
references.citation: Lancet. 2005 Oct 8;366(9493):1303-14
references.pmid: 16214602
references.citation: Carcinogenesis. 2010 May;31(5):842-6
references.pmid: 20172949
references.citation: Asian Pac J Cancer Prev. 2012;13(5):1963-9
references.pmid: 22901155
references.citation: Surg Oncol. 2009 Mar;18(1):51-6
references.pmid: 18715780
references.citation: J Natl Cancer Inst. 2001 Nov 7;93(21):1644-51
references.pmid: 11698569
references.citation: Br J Cancer. 2009 Jan 13;100(1):178-80
references.pmid: 19018260
references.citation: Scand J Gastroenterol. 2002 Oct;37(10):1205-11
references.pmid: 12408527
references.citation: Gut. 2002 Oct;51(4):562-6
references.pmid: 12235081
references.citation: Br J Cancer. 2010 Jun 29;103(1):115-9
references.pmid: 20517308
references.citation: Cancer. 2002 Nov 1;95(9):1946-53
references.pmid: 12404289
references.citation: Hepatology. 2011 Apr;53(4):1217-25
references.pmid: 21480326
references.citation: Hepatology. 1997 Apr;25(4):787-90
references.pmid: 9096577
references.citation: Hepatology. 2007 May;45(5):1267-74
references.pmid: 17464998
references.citation: Dig Surg. 2008;25(2):126-32
references.pmid: 18446034
references.citation: Cancer Sci. 2004 Jul;95(7):592-5
references.pmid: 15245596
references.citation: Int J Cancer. 2008 Apr 15;122(8):1849-53
references.pmid: 18076042
references.citation: Liver Int. 2010 Feb;30(2):215-21
references.pmid: 19840244
references.citation: World J Gastroenterol. 2013 Jan 28;19(4):457-62
references.pmid: 23382624
references.citation: Br J Cancer. 2007 Dec 3;97(11):1577-82
references.pmid: 18000509
references.citation: Hepatology. 2011 Jul;54(1):173-84
references.pmid: 21488076
references.citation: CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21
references.pmid: 20554718